Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2022-06-10
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Unsafe Alcohol Use in HIV-Positive Individuals
NCT00371969
Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth
NCT01969461
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
NCT00103532
Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers
NCT03974061
Reducing Alcohol Dependence Among HIV-Positive Individuals
NCT02501057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Contingent Condition
Participants will wear a wrist biosensor with daily CM based on smartphone breathalyzer readings for 30 days; then for a second 30 days, encouragement to reduce drinking but payment not based on drinking.
Counseling
Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning.
mHealth and CM
Participants will wear a wrist biosensor with daily CM based on smartphone breathalyzer readings for 30 days; then for a second 30 days, weekly CM based on wrist biosensor readings. Participants will also interact with a mobile health application to facilitate drinking reduction.
Counseling
Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning
mHealth
Participants will engage with an application designed to gamify drinking reduction.
CM
Participants will wear a wrist biosensor with daily CM based on smartphone breathalyzer readings for 30 days; then for a second 30 days, weekly CM based on wrist biosensor readings
Counseling
Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Counseling
Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning
mHealth
Participants will engage with an application designed to gamify drinking reduction.
Counseling
Brief counseling including personalized feedback on breath alcohol concentration, cognitive task performance and physical functioning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV positive
* Fluency in English
* Willingness to attempt alcohol abstinence for at least 30 days and then to attempt alcohol use on fewer days than at baseline after that
* Willingness to use smartphone applications and biosensor devices (i.e., breathalyzer device and wrist sensor) for alcohol use reduction purposes in the study. If participants do not have a compatible smartphone to use, they will be loaned one by the study
Exclusion Criteria
* Current alcohol withdrawal as indicated by a score of 8 or higher on the Clinical Institute Withdrawal Scale (CIWA; Sullivan et al., 1989) or lifetime history of medically assisted detoxification
* Two positive breath alcohol concentration (BrAC) readings (i.e., \> 0.00%) at an in-person screening appointment. After participants blow their first positive BrAC, they will be allowed to reschedule and participate at another time, however if they blow a second positive BrAC, they will be excluded from this study and offered referrals for alcohol treatment.
* Currently seeking or past-12-month history of inpatient or intensive treatment for addictive behaviors
* Psychosis or other severe psychiatric disability
* Pregnancy, nursing or lack of reliable birth control use for women who have not yet reached menopause
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
University of Louisville
OTHER
Florida State University
OTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Leeman, Ph.D
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Coral Gables, Florida, United States
University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO00035889
Identifier Type: OTHER
Identifier Source: secondary_id
OCR41499
Identifier Type: OTHER
Identifier Source: secondary_id
CED000000577
Identifier Type: OTHER
Identifier Source: secondary_id
CED000000577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.